Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)

por Omar, N.E., Fahmy Soliman, A.I., Eshra, M., Saeed, T., Hamad, A., Abou-Ali, A.
Publicado 2021

The extent of involvement of ouabain, hippocampal expression of Na(+)/K(+)-ATPase, and corticosterone/melatonin receptors ratio in modifying stress-induced behavior differs accordi...

por Abdelmissih, S., Sayed, W.M., Rashed, L.A., Kamel, M.M., Eshra, M.A., Attallah, M.I., El-Naggar, R.A-R.
Publicado 2022